|
1
|
Metzger DE, Stahlman MT and Shannon JM:
Misexpression of ELF5 disrupts lung branching and inhibits
epithelial differentiation. Dev Biol. 320:149–160. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Metzger DE, Xu Y and Shannon JM: Elf5 is
an epithelium-specific, fibroblast growth factor-sensitive
transcription factor in the embryonic lung. Dev Dyn. 236:1175–1192.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yao B, Zhao J, Li Y, Li H, Hu Z, Pan P,
Zhang Y, Du E, Liu R and Xu Y: Elf5 inhibits TGF-β-driven
epithelial-mesenchymal transition in prostate cancer by repressing
SMAD3 activation. Prostate. 75:872–882. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li K, Guo Y, Yang X, Zhang Z, Zhang C and
Xu Y: ELF5-mediated AR activation regulates prostate cancer
progression. Sci Rep. 7:427592017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu B, Cao X, Liang X, Zhang X, Zhang W,
Sun G and Wang D: Epigenetic regulation of Elf5 is associated with
epithelial-mesenchymal transition in urothelial cancer. PLoS One.
10:e01175102015. View Article : Google Scholar :
|
|
6
|
Yan H, Qiu L, Xie X, Yang H, Liu Y, Lin X
and Huang H: ELF5 in epithelial ovarian carcinoma tissues and
biological behavior in ovarian carcinoma cells. Oncol Rep.
37:1412–1418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hu Y, Yan Y, Xu Y, Yang H, Fang L, Liu Y,
Li X, Li Q and Yan H: Expression and clinical significance of WWOX,
Elf5, Snail1 and EMT related factors in epithelial ovarian cancer.
Oncol Lett. 19:1281–1290. 2020.
|
|
8
|
Singh S, Kumar S, Srivastava RK, Nandi A,
Thacker G, Muralil H, Kim S, Baldeon M, Tobias J, Blanco MA, et al:
Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and
metastasis of triple-negative breast cancer through interferon-γ
signalling. Nat Cell Biol. 22:591–602. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Piggin CL, Roden DL, Law AMK, Molloy MP,
Krisp C, Swarbrick A, Naylor MJ, Kalyuga M, Kaplan W, Oakes SR, et
al: ELF5 modulates the estrogen receptor cistrome in breast cancer.
PLoS Genet. 16:e10085312020. View Article : Google Scholar :
|
|
10
|
Yao F, Wang X, Cui ZK, Lan H, Ai X, Song
Q, Chen Z, Yang J, Wu B and Bai X: ETS2 promotes
epithelial-to-mesenchymal transition in renal fibrosis by targeting
JUNB transcription. Lab Invest. 100:438–453. 2020. View Article : Google Scholar
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
12
|
Takasaki Y, Deng JS and Tan EM: A nuclear
antigen associated with cell proliferation and blast
transformation. J Exp Med. 154:1899–1909. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Juríková M, Danihel Ľ, Polák Š and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Castro-Mondragon JA, Riudavets-Puig R,
Rauluseviciute I, Lemma RB, Turchi L, Blanc-Mathieu R, Lucas J,
Boddie P, Khan A, Manosalva Pérez N, et al: JASPAR 2022: The 9th
release of the open-access database of transcription factor binding
profiles. Nucleic Acids Res. 50(D1): D165–D173. 2022. View Article : Google Scholar :
|
|
15
|
Barta JA, Powell CA and Wisnivesky JP:
Global epidemiology of lung cancer. Ann Glob Health. 85:82019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou J, Chehab R, Tkalcevic J, Naylor MJ,
Harris J, Wilson TJ, Tsao S, Tellis I, Zavarsek S, Xu D, et al:
Elf5 is essential for early embryogenesis and mammary gland
development during pregnancy and lactation. EMBO J. 24:635–644.
2005. View Article : Google Scholar :
|
|
18
|
Oakes SR, Naylor MJ, Asselin-Labat ML,
Blazek KD, Gardiner-Garden M, Hilton HN, Kazlauskas M, Pritchard
MA, Chodosh LA, Pfeffer PL, et al: The Ets transcription factor
Elf5 specifies mammary alveolar cell fate. Gene Dev. 22:581–586.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kalyuga M, Gallego-Ortega D, Lee HJ, Roden
DL, Cowley MJ, Caldon CE, Stone A, Allerdice SL, Valdes-Mora F,
Launchbury R, et al: ELF5 suppresses estrogen sensitivity and
underpins the acquisition of antiestrogen resistance in luminal
breast cancer. PLoS Biol. 10:e10014612012. View Article : Google Scholar
|
|
20
|
Luk IY, Reehorst CM and Mariadason JM:
ELF3, ELF5, EHF and SPDEF transcription factors in tissue
homeostasis and cancer. Molecules. 23:21912018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bonner AE, Lemon WJ, Devereux TR, Lubet RA
and You M: Molecular profiling of mouse lung tumors: Association
with tumor progression, lung development, and human lung
adenocarcinomas. Oncogene. 23:1166–1176. 2004. View Article : Google Scholar
|
|
22
|
Miura K, Bowman ED, Simon R, Peng AC,
Robles AI, Jones RT, Katagiri T, He P, Mizukami H, Charboneau L, et
al: Laser capture microdissection and microarray expression
analysis of lung adenocarcinoma reveals tobacco smoking- and
prognosis-related molecular profiles. Cancer Res. 62:3244–3250.
2002.PubMed/NCBI
|
|
23
|
Zhang K, Wang J, Yang L, Yuan YC, Tong TR,
Wu J, Yun X, Bonner M, Pangeni R, Liu Z, et al: Targeting histone
methyltransferase G9a inhibits growth and Wnt signaling pathway by
epigenetically regulating HP1α and APC2 gene expression in
non-small cell lung cancer. Mol Cancer. 17:1532018. View Article : Google Scholar
|
|
24
|
Croy HE, Fuller CN, Giannotti J, Robinson
P, Foley AVA, Yamulla RJ, Cosgriff S, Greaves BD, von Kleeck RA, An
HH, et al: The Poly(ADP-ribose) polymerase enzyme tankyrase
antagonizes activity of the β-catenin destruction complex through
ADP-ribosylation of axin and APC2. J Biol Chem. 291:12747–12760.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dai B, Kong DL, Tian J, Liu TW, Zhou H and
Wang ZF: microRNA-1205 promotes cell growth by targeting APC2 in
lung adenocarcinoma. Eur Rev Med Pharmacol Sci. 23:1125–1133.
2019.PubMed/NCBI
|
|
26
|
Dong Y, Wu B, Wang X, Lu F, Li Q and Zhao
Q: High miR-3648 expression and low APC2 expression are associated
with shorter survival and tumor progression in NSCLC. Histol
Histopathol. 37:355–364. 2022.
|
|
27
|
Ge YX, Wang CH, Hu FY, Pan LX, Min J, Niu
KY, Zhang L, Li J and Xu T: New advances of TMEM88 in cancer
initiation and progression, with special emphasis on Wnt signaling
pathway. J Cell Physiol. 233:79–87. 2018. View Article : Google Scholar
|
|
28
|
Rimerman RA, Gellert-Randleman A and Diehl
JA: Wnt1 and MEK1 cooperate to promote cyclin D1 accumulation and
cellular transformation. J Biol Chem. 275:14736–14742. 2000.
View Article : Google Scholar
|
|
29
|
Varma S, Cao Y, Tagne JB, Lakshminarayanan
M, Li J, Friedman TB, Morell RJ, Warburton D, Kotton DN and Ramirez
MI: The transcription factors Grainyhead-like 2 and NK2-homeobox 1
form a regulatory loop that coordinates lung epithelial cell
morphogenesis and differentiation. J Biol Chem. 287:37282–37295.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kersbergen A, Best SA, Dworkin S, Ah-Cann
C, de Vries ME, Asselin-Labat ML, Ritchie ME, Jane SM and
Sutherland KD: Lung morphogenesis is orchestrated through
Grainyhead-like 2 (Grhl2) transcriptional programs. Dev Biol.
443:1–9. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gao X, Bali AS, Randell SH and Hogan BLM:
GRHL2 coordinates regeneration of a polarized mucociliary
epithelium from basal stem cells. J Cell Biol. 211:669–682. 2015.
View Article : Google Scholar :
|
|
32
|
Pan X, Zhang R, Xie C, Gan M, Yao S, Yao
YB, Jin J, Han T, Huang Y, Gong Y, et al: GRHL2 suppresses tumor
metastasis via regulation of transcriptional activity of RhoG in
non-small cell lung cancer. Am J Transl Res. 9:4217–4226.
2017.PubMed/NCBI
|
|
33
|
Werner S, Frey S, Riethdorf S, Schulze C,
Alawi M, Kling L, Vafaizadeh V, Sauter G, Terracciano L, Schumacher
U, et al: Dual roles of the transcription factor grainyhead-like 2
(GRHL2) in breast cancer. J Biol Chem. 288:22993–23008. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He J, Feng C, Zhu H, Wu S, Jin P and Xu T:
Grainyhead-like 2 as a double-edged sword in development and
cancer. Am J Transl Res. 12:310–331. 2020.PubMed/NCBI
|
